Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-06 4:29 pm Sale | 2025-12-31 | 13G | Athira Pharma, Inc. ATHA | Baselake Partners, LP | 75,789 1.900% | -121,692 (-61.62%) | Filing History |
| 2026-01-16 4:46 pm Sale | 2026-01-16 | 13D | Athira Pharma, Inc. ATHA | Perceptive Advisors LLC | 1,859,322 19.990% | -9,728 (-0.52%) | Filing History |
| 2026-01-08 5:29 pm Purchase | 2026-01-06 | 13G | Athira Pharma, Inc. ATHA | ACORN BIOVENTURES, L.P. | 596,068 6.200% | 94,329 (+18.80%) | Filing History |
| 2025-12-23 5:16 pm Purchase | 2025-12-23 | 13D | Athira Pharma, Inc. ATHA | Perceptive Advisors LLC | 1,869,050 20.100% | 1,319,026 (+239.81%) | Filing History |
| 2025-12-23 4:46 pm Purchase | 2025-12-22 | 13G | Athira Pharma, Inc. ATHA | ACORN BIOVENTURES, L.P. | 501,739 5.200% | 501,739 (New Position) | Filing History |
| 2025-12-22 4:30 pm Purchase | 2025-12-18 | 13D | Athira Pharma, Inc. ATHA | Perceptive Advisors LLC | 550,024 13.900% | 550,024 (New Position) | Filing History |
| 2025-12-18 3:47 pm Sale | 2025-12-18 | 13G | Athira Pharma, Inc. ATHA | BML Investment Partners, L.P. | 0 0.000% | -302,716 (Position Closed) | Filing History |
| 2025-11-14 4:06 pm Purchase | 2025-11-07 | 13G | Athira Pharma, Inc. ATHA | Baselake Partners, LP | 197,481 5.000% | 197,481 (New Position) | Filing History |
| 2025-10-10 4:41 pm Sale | 2025-10-01 | 13G | Athira Pharma, Inc. ATHA | Oliveira Steven Michael | 161,218 4.088% | -38,247 (-19.17%) | Filing History |
| 2025-04-16 4:22 pm Purchase | 2025-04-14 | 13G | Athira Pharma, Inc. ATHA | Oliveira Steven Michael | 199,465 5.109% | 199,465 (New Position) | Filing History |
| 2025-02-14 10:21 am Purchase | 2024-12-31 | 13G | Athira Pharma, Inc. ATHA | BML Investment Partners, L.P. | 302,716 7.800% | 54,272 (+21.84%) | Filing History |
| 2025-02-14 09:59 am Unchanged | 2024-12-31 | 13G | Athira Pharma, Inc. ATHA | BML Investment Partners, L.P. | 248,445 6.500% | 0 (Unchanged) | Filing History |
| 2024-11-14 4:17 pm Sale | 2024-09-30 | 13G | Athira Pharma, Inc. ATHA | Baker Bros. Advisors LP | 0 0.000% | -315,381 (Position Closed) | Filing History |
| 2024-11-07 1:15 pm Purchase | 2024-11-01 | 13G | Athira Pharma, Inc. ATHA | BML Investment Partners, L.P. | 248,445 6.500% | 248,445 (New Position) | Filing History |
| 2024-10-31 4:16 pm Purchase | 2024-10-30 | 13D | Athira Pharma, Inc. ATHA | Perceptive Advisors LLC | 547,935 14.200% | 2,090 (+0.38%) | Filing History |
| 2024-02-14 4:21 pm Purchase | 2023-12-31 | 13G | Athira Pharma, Inc. ATHA | Baker Bros. Advisors LP | 315,381 8.300% | 315,381 (New Position) | Filing History |
| 2023-12-29 5:15 pm Purchase | 2023-12-27 | 13D | Athira Pharma, Inc. ATHA | Perceptive Advisors LLC | 545,845 14.300% | 64,730 (+13.45%) | Filing History |
| 2023-07-07 4:35 pm Sale | 2023-06-30 | 13G | Athira Pharma, Inc. ATHA | BlackRock Inc. BLK | 66,977 1.800% | -169,345 (-71.66%) | Filing History |
| 2023-04-20 5:27 pm Purchase | 2023-04-10 | 13G | Athira Pharma, Inc. ATHA | KAYNE RICHARD A | 198,367 5.300% | 198,367 (New Position) | Filing History |
| 2023-02-14 10:27 am Sale | 2022-12-31 | 13G | Athira Pharma, Inc. ATHA | RTW Investments, LP | 0 0.000% | -190,656 (Position Closed) | Filing History |